Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. Posted 7 Million Yuan Net Loss in First Quarter of 2022

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. (杭州天目山药业股份有限公司) (600671.SH) reported a net loss of 7 million yuan in the first quarter of 2022, widening 109.7% year-on-year.

Meanwhile, the company posted 26.1 million yuan in revenue, down 33.1% year-on-year.

At the end of the reporting period, it had 390.9 million yuan in total assets and 333.4 million yuan in total liabilities, with a liability-to-asset ratio of 85.3%.